Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 15, 2026
Sale
Shares
161,656
Price
$34.22
Total Value
$5.53M
Shares Held After
271,783
% of Holdings
37.3%
Feb 15, 2026
Purchase
Shares
264,551
Price
$1.26
Total Value
$333.33K
Shares Held After
29,781,952
% of Holdings
0.9%
Feb 15, 2026
Purchase
Shares
1,601,941
Price
$1.03
Total Value
$1.65M
Shares Held After
29,517,401
% of Holdings
5.4%
Feb 13, 2026
Sale
Shares
22,191
Price
$243.71
Total Value
$5.41M
Shares Held After
25,020
% of Holdings
47.0%
Feb 13, 2026
Sale
Shares
19,368
Price
$243.76
Total Value
$4.72M
Shares Held After
25,020
% of Holdings
43.6%

EXELIXIS, INC. (EXEL)

Oliver Bob — Director
Feb 13, 2026
Sale
Shares
21,162
Price
$43.90
Total Value
$929.01K
Shares Held After
21,120
% of Holdings
50.0%

EXELIXIS, INC. (EXEL)

Oliver Bob — Director
Feb 13, 2026
Sale
Shares
9,088
Price
$43.61
Total Value
$396.33K
Shares Held After
42,282
% of Holdings
17.7%
Feb 13, 2026
Sale
Shares
3,856
Price
$43.79
Total Value
$168.85K
Shares Held After
17,524
% of Holdings
18.0%
Feb 13, 2026
Sale
Shares
34,278
Price
$43.00
Total Value
$1.47M
Shares Held After
1,042,579
% of Holdings
3.2%
Feb 13, 2026
Sale
Shares
7,040
Price
$51.96
Total Value
$365.82K
Shares Held After
43,720
% of Holdings
13.9%
Feb 13, 2026
Sale
Shares
12,116
Price
$18.21
Total Value
$220.63K
Shares Held After
339,254
% of Holdings
3.4%

ARVINAS, INC. (ARVN)

Loomis David K — Chief Accounting Officer
Feb 13, 2026
Sale
Shares
1,016
Price
$11.89
Total Value
$12.08K
Shares Held After
30,800
% of Holdings
3.2%

ARVINAS, INC. (ARVN)

Berkowitz Noah — Chief Medical Officer
Feb 13, 2026
Sale
Shares
5,685
Price
$11.89
Total Value
$67.59K
Shares Held After
163,938
% of Holdings
3.4%

ARVINAS, INC. (ARVN)

Cacace Angela M — Chief Scientific Officer
Feb 13, 2026
Sale
Shares
4,592
Price
$11.89
Total Value
$54.60K
Shares Held After
151,232
% of Holdings
2.9%

ARVINAS, INC. (ARVN)

Saik Andrew — Chief Financial Officer
Feb 13, 2026
Sale
Shares
5,134
Price
$11.89
Total Value
$61.04K
Shares Held After
159,267
% of Holdings
3.1%

ARVINAS, INC. (ARVN)

Teel Randy — Director
Feb 13, 2026
Sale
Shares
4,403
Price
$11.89
Total Value
$52.35K
Shares Held After
154,482
% of Holdings
2.8%
Feb 13, 2026
Sale
Shares
12,279
Price
$3.31
Total Value
$40.67K
Shares Held After
1,052,045
% of Holdings
1.2%

ROCKET PHARMACEUTICALS, INC. (RCKT)

Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Feb 13, 2026
Sale
Shares
3,726
Price
$3.31
Total Value
$12.34K
Shares Held After
92,176
% of Holdings
3.9%
Feb 13, 2026
Sale
Shares
12,253
Price
$3.31
Total Value
$40.58K
Shares Held After
683,376
% of Holdings
1.8%

Roivant Sciences Ltd. (ROIV)

Venker Eric — President & Immunovant CEO
Feb 13, 2026
Sale
Shares
200,000
Price
$26.49
Total Value
$5.30M
Shares Held After
1,654,597
% of Holdings
10.8%
Feb 13, 2026
Sale
Shares
11,112,052
Price
$21.00
Total Value
$233.35M
Shares Held After
0
% of Holdings
100.0%
Feb 13, 2026
Sale
Shares
13,871
Price
$7.78
Total Value
$107.95K
Shares Held After
174,316
% of Holdings
7.4%
Feb 13, 2026
Purchase
Shares
57,952
Price
$1.31
Total Value
$75.88K
Shares Held After
1,443,641
% of Holdings
4.0%

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Moran Sean F. — Chief Financial Officer
Feb 13, 2026
Sale
Shares
4,701
Price
$7.78
Total Value
$36.59K
Shares Held After
96,694
% of Holdings
4.6%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Feb 13, 2026
Sale
Shares
1,500
Price
$499.99
Total Value
$749.99K
Shares Held After
46,132
% of Holdings
3.1%
Feb 13, 2026
Sale
Shares
2,184
Price
$48.26
Total Value
$105.40K
Shares Held After
21,084
% of Holdings
9.4%
Feb 13, 2026
Purchase
Shares
291
Price
$63.00
Total Value
$18.33K
Shares Held After
450,335
% of Holdings
0.1%

BRUKER CORP (BRKR)

Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Feb 13, 2026
Sale
Shares
2,000
Price
$36.94
Total Value
$73.88K
Shares Held After
128,443
% of Holdings
1.5%
Feb 13, 2026
Sale
Shares
266
Price
$500.00
Total Value
$133.00K
Shares Held After
4,299
% of Holdings
5.8%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Biller Jonathan — EVP and Chief Legal Officer
Feb 13, 2026
Sale
Shares
988
Price
$499.00
Total Value
$493.01K
Shares Held After
16,838
% of Holdings
5.5%

Vir Biotechnology, Inc. (VIR)

Sabatini Brent — SVP, Chief Accounting Officer
Feb 13, 2026
Sale
Shares
1,530
Price
$7.79
Total Value
$11.92K
Shares Held After
47,872
% of Holdings
3.1%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 13, 2026
Sale
Shares
20,000
Price
$23.53
Total Value
$470.60K
Shares Held After
43,298
% of Holdings
31.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Feb 13, 2026
Sale
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
23,305
% of Holdings
7.8%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. — EVP, Chief Financial Officer
Feb 13, 2026
Sale
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
59,802
% of Holdings
3.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga — EVP, Chief Commercial Officer
Feb 13, 2026
Sale
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
31,769
% of Holdings
5.8%
Feb 13, 2026
Sale
Shares
6,958
Price
$310.08
Total Value
$2.16M
Shares Held After
85,662
% of Holdings
7.5%
Feb 13, 2026
Sale
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
24,848
% of Holdings
8.3%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
351
Price
$209.10
Total Value
$73.39K
Shares Held After
68,068
% of Holdings
0.5%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
1,619
Price
$208.21
Total Value
$337.09K
Shares Held After
68,419
% of Holdings
2.3%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
3,500
Price
$207.08
Total Value
$724.79K
Shares Held After
70,038
% of Holdings
4.8%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
10,122
Price
$206.37
Total Value
$2.09M
Shares Held After
73,538
% of Holdings
12.1%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
10,573
Price
$205.21
Total Value
$2.17M
Shares Held After
83,660
% of Holdings
11.2%
Feb 13, 2026
Sale
Shares
2,000
Price
$102.09
Total Value
$204.18K
Shares Held After
0
% of Holdings
100.0%

ANI PHARMACEUTICALS INC (ANIP)

Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Feb 13, 2026
Sale
Shares
500
Price
$76.80
Total Value
$38.40K
Shares Held After
69,329
% of Holdings
0.7%
Feb 13, 2026
Sale
Shares
10,000
Price
$5.81
Total Value
$58.14K
Shares Held After
204,657
% of Holdings
4.7%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 13, 2026
Sale
Shares
1,750
Price
$50.04
Total Value
$87.57K
Shares Held After
306,250
% of Holdings
0.6%

Hyperfine, Inc. (HYPR)

TEISSEYRE THOMAS — Chief Operating Officer
Feb 13, 2026
Sale
Shares
821
Price
$1.11
Total Value
$912.54
Shares Held After
378,836
% of Holdings
0.2%
Feb 13, 2026
Purchase
Shares
16,100
Price
$8.96
Total Value
$144.27K
Shares Held After
258,792
% of Holdings
6.2%
Feb 13, 2026
Purchase
Shares
11,092
Price
$9.14
Total Value
$101.41K
Shares Held After
242,692
% of Holdings
4.6%
Feb 13, 2026
Sale
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Version: v26.3.33